Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-6232

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-6232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\ra\desktop\1.jpg (5a5eca60 Figure 01)

This is a clinical chart showing the baseline SBP (systolic blood pressure) readings in mmHg. Four different medications were used in the study and their dosages are mentioned. The aim was to keep the SBP value less than 140 mmHg.*

FDA Label Image

C:\users\ra\desktop\2.jpg (5a5eca60 Figure 02)

This text appears to be a table showing blood pressure readings and medication dosages. It indicates that the person has a baseline diastolic blood pressure (DBP) of 105 mmHg and is taking either Valsartan-HCTZ at a dosage of 320/25 mg or just Valsartan at a dosage of 320 mg. The text also references Hydrochlorothiazide at a dosage of 25 mg and a placebo. Overall, this suggests a medical context related to cardiovascular health and hypertension management.*

FDA Label Image

C:\users\ra\desktop\3.jpg (5a5eca60 Figure 03)

The text provides a blood pressure value of 140, 145, 150, 155, 160, 165, 170, 175, and 180 mmHg. Among these values, there are three treatments mentioned: Valsartan-HCTZ 320/25 mg, Valsartan 320 mg, and placebo. The target value for SBP is less than 130 mmHg.*

FDA Label Image

C:\users\ra\desktop\4.jpg (5a5eca60 Figure 04)

The text describes a table that shows the effect of different drugs on DBP (Diastolic Blood Pressure) in mmHg (millimeters of mercury). The drugs are Valsartan-HCTZ 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The baseline DBP is also shown.*

FDA Label Image

C:\users\ra\desktop\5.jpg (5a5eca60 Figure 05)

FDA Label Image

C:\users\ra\desktop\6.jpg (5a5eca60 Figure 06)

FDA Label Image

Label Image (Lbl500906232)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.